文献速递急性肾损伤慢性肾脏病

肾脏老化的分子机制

Molecular mechanisms of renal aging.
PubMed 文献 · Kidney Int · 2017-07-18

流行病学、临床和分子证据提示衰老是急性肾损伤和慢性肾脏病发病率上升的重要驱动因素。该综述总结参与肾脏老化表型的细胞与分子过程:肾小球滤过率下降、功能性肾单位丢失,以及足细胞肥大、肾小球硬化、肾小管萎缩和微血管稀疏等机制,并讨论细胞衰老、自噬改变和炎症系统差异,以及热量限制模拟物、RAAS 抑制和衰老细胞治疗等潜在干预。

要点

  • 肾脏老化的主要临床表现是肾小球滤过率下降,结构对应为功能性肾单位丢失。
  • 老年患者急性肾损伤后肾功能恢复显著更差,可能与细胞衰老导致再生能力下降有关。
  • 清除衰老细胞可减轻肾脏老化,衰老细胞治疗是潜在治疗方向。

核心结论

  • 衰老是急性肾损伤和慢性肾脏病发病率上升的重要贡献因素,其分子机制可能成为未来治疗靶点。
  • 肾脏老化的主要临床发现是肾小球滤过率下降,结构对应为功能性肾单位丢失。
  • 清除衰老细胞可减轻肾脏老化,支持细胞衰老在肾脏老化中的作用。

研究设计与样本

  • 本文为综述,总结近期关于肾脏老化表型的细胞和分子过程的研究证据。

主要发现

  • 肾脏老化机制涉及足细胞肥大、肾小球硬化、肾小管萎缩和逐渐的微血管稀疏。
  • 老年患者急性肾损伤后肾功能恢复显著更差,再生能力下降是老化标志,可能由细胞衰老引起。
  • 衰老细胞积累可解释修复不足和功能丧失。
  • 其他潜在机制包括自噬改变作为肾脏应激反应紊乱的重要组分,以及炎症系统的功能差异。

临床怎么用

  • 针对年龄相关问题的有前景治疗措施包括热量限制模拟物、药理学抑制肾素-血管紧张素-醛固酮系统和以减少衰老细胞数量为目标的新型衰老细胞治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Epidemiologic, clinical, and molecular evidence suggest that aging is a major contributor to the increasing incidence of acute kidney injury and chronic kidney disease. The aging kidney undergoes complex changes that predispose to renal pathology. The underlying molecular mechanisms could be the target of therapeutic strategies in the future. Here, we summarize recent insight into cellular and molecular processes that have been shown to contribute to the renal aging phenotype.The main clinical finding of renal aging is the decrease in glomerular filtration rate, and its structural correlate is the loss of functioning nephrons. Mechanistically, this has been linked to different processes, such as podocyte hypertrophy, glomerulosclerosis, tubular atrophy, and gradual microvascular rarefaction. Renal functional recovery after an episode of acute kidney injury is significantly worse in elderly patients. This decreased regenerative potential, which is a hallmark of the aging process, may be caused by cellular senescence. Accumulation of senescent cells could explain insufficient repair and functional loss, a view that has been strengthened by recent studies showing that removal of senescent cells results in attenuation of renal aging. Other potential mechanisms are alterations in autophagy as an important component of a disturbed renal stress response and functional differences in the inflammatory system. Promising therapeutic measures to counteract these age-related problems include mimetics of caloric restriction, pharmacologic renin-angiotensin-aldosterone system inhibition, and novel strategies of senotherapy with the goal of reducing the number of senescent cells to decrease aging-related disease in the kidney.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Schmitt R, Melk A. Molecular mechanisms of renal aging. Kidney Int. 2017. PMID: 28729036. doi:10.1016/j.kint.2017.02.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。